Founded Year
1986Stage
Acq - P2P | AcquiredValuation
$0000About Osteotech
Osteotech, Inc. is a global leader in the processing of human bone and connective tissue for transplantation and an innovator in the development, manufacturing and marketing of biologic, biomaterial and device systems for musculoskeletal surgery. With a particular focus on spinal, trauma, and total joint revision procedures, the Company's current and development-stage technologies address needs within numerous musculoskeletal disciplines.
Osteotech Headquarter Location
51 James Way
Eatontown, New Jersey, 07724,
United States
732-542-2800
Latest Osteotech News
Jul 17, 2013
Send to a Friend Font Size: Increase Decrease Osteotech/Medtronic On August 17, 2010, Osteotech (Nasdaq: OSTE) announced an agreement to be acquired by Medtronic Inc., (NYSE: MDT) for $6.50 per share in cash, or approximately $123 million. Osteotech is a leader in the growing field of biologic products for regenerative healing, and has pioneered several innovative technology platforms including Grafton demineralized bone matrix, a family of products which has a large and growing body of evidence supporting its best-in-class bone generating capabilities.
Osteotech Patents
Osteotech has filed 12 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
12/5/2007 | 5/10/2011 | Digestive system, Implants (medicine), Prosthetics, Orthopedic surgical procedures, Biomaterials | Grant | |
Application Date | 12/5/2007 | ||||
|---|---|---|---|---|---|
Grant Date | 5/10/2011 | ||||
Title | |||||
Related Topics | Digestive system, Implants (medicine), Prosthetics, Orthopedic surgical procedures, Biomaterials | ||||
Status | Grant |